T-cells from common colds could help scientists make the “Holy Grail”: A variant-proof COVID vaccine
(Worthy News) – T-cells generated as part of the body’s natural immune response to the common cold may help protect against serious illness from COVID-19, according to a study carried out in the U.K. Researchers at Imperial College London told CBS News the findings could help scientists create vaccines that remain more effective against new variants of the coronavirus.
The study, which was peer reviewed and published in the journal “Nature Communications,” began in September 2020 and looked at 52 household contacts of people who had tested positive for COVID-19. It found that 26 people who were exposed to the coronavirus but did not get sick had significantly higher cross-reactive T-cells, generated by previous common colds, than those who did become ill with COVID. [ Source: CBS News (Read More…) ]
Worthy News reports from a biblical worldview with a commitment to accuracy, transparency, and editorial independence. Learn more about About Worthy News, our Editorial Standards, AI Use Policy, Ownership of Worthy News, News Tips and Corrections, and Worthy News Staff.
💡 Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.
📢 Social media algorithms push content further when there’s more engagement — so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌